← The Wire
TRVINasdaq
Trevi Therapeutics, Inc.
Pharmaceutical Preparations · DE · CIK 1563880
Develops and commercializes Haduvio for chronic cough in adults with lung diseases
$2.02B
Market cap
$18.63
Last close
+2.6%
1D
+5.2%
5D
2.9M
Volume
Price · last 39 sessions+29.6%
May 4L $13.24 · H $18.63Jun 29
152
Total filings
Jun 4, 2026
Last filing
12/31
Fiscal year end
424B5424B5Apr 17, 2026424B5424B5Apr 16, 2026424B5424B5Jun 4, 2025424B5424B5Jun 2, 2025424B5424B5Dec 16, 2024424B5424B5Sep 23, 2022424B5424B5Sep 22, 2022424B5424B5May 16, 2022
Similar companies
Comparable business profile · signals at a glance